As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.
You’ve Taken Every Precaution and So Have We
Many cancer patients chose to reschedule or delay routine care and treatment with the permission of physicians to minimize the risk of exposure to COVID-19. Now that we are past the peak of the pandemic, Rutgers Cancer Institute of New Jersey would like to welcome you back. Chief Medical Officer Deborah Toppmeyer, MD and Chief Nursing Officer Carolyn Hayes, RN, PhD, NEA-BC share the safeguards and precautions put into place to keep patients and staff safe and comfortable when returning for cancer care. Watch here
Updated Guidelines for Cancer Prevention
Simple lifestyle changes can impact one’s risk of developing cancer. Rutgers Cancer Institute of New Jersey Chief of Cancer Epidemiology and Health Outcomes Elisa V. Bandera, MD, PhD, who is also a professor of medicine at Rutgers Robert Wood Johnson Medical School and a professor of epidemiology at Rutgers School of Public Health, recently contributed to the American Cancer Society’s updated nutrition and physical activity guidelines. The latest guidelines emphasize increasing the recommended amount of physical activity and maintaining a healthy body weight to reduce cancer risk. Learn more
Cancer Surgery in the Face of COVID-19
Cancer patients might still have heightened concerns over rescheduling a postponed surgery or scheduling a new surgery right now due to COVID-19. Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health have instituted extra surgical care safeguards to ensure the safety of patients and medical staff at their facilities to safely resume surgical treatment for those patients for which a delay was deemed okay. Rutgers Cancer Institute Chief Surgical Officer H. Richard Alexander, Jr., MD, FACS, professor of surgery at Rutgers Robert Wood Johnson Medical School and Regional Director of Surgery for Monmouth Medical Center shares more.
Exploring a Potential Link between Tissue Match Genes and COVID-19
When diagnosed with COVID-19, some people experience respiratory and cardiovascular distress, while others have no symptoms at all. Rutgers Cancer Institute of New Jersey researcher, Jeffrey Rosenfeld, PhD, assistant professor of pathology and laboratory medicine at Rutgers Robert Wood Johnson Medical School, is exploring how different versions of immune-vital genes screened for transplant matching may shape who develops or resists COVID-19. The study is being conducted in collaboration with Root, a scientific company that helps interpret genetic variation, and the Gift of Life Marrow Registry. Learn more
